Cargando…
Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
BACKGROUND: Recent concerns about potential overdiagnosis and overtreatment of ductal carcinoma in situ of the breast (DCIS) render evaluation of late effects of treatment, such as cardiovascular disease (CVD), of great importance. We studied cardiovascular morbidity and mortality in a large populat...
Autores principales: | Boekel, Naomi B., Schaapveld, Michael, Gietema, Jourik A., Rutgers, Emiel J. T., Versteegh, Michel I. M., Visser, Otto, Aleman, Berthe M. P., van Leeuwen, Flora E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151854/ https://www.ncbi.nlm.nih.gov/pubmed/25128694 http://dx.doi.org/10.1093/jnci/dju156 |
Ejemplares similares
-
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2018) -
Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018) -
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017) -
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016) -
Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
por: Jacobse, Judy N., et al.
Publicado: (2019)